{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:35:26Z","timestamp":1791509726933,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72404205"],"award-info":[{"award-number":["72404205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Tianjin, China","award":["23JCQNJC01650"],"award-info":[{"award-number":["23JCQNJC01650"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"DOI":"10.1186\/s12955-025-02461-0","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T01:37:12Z","timestamp":1764725832000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of measurement properties of the Health Assessment Questionnaire-Disability Index (HAQ-DI) among gout patients in China"],"prefix":"10.1186","volume":"24","author":[{"given":"Nuoming","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shitong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"4","key":"2461_CR1","first-page":"1234","volume":"71","author":"K Ashiq","year":"2021","unstructured":"Ashiq K, Bajwa MA, Tanveer S, Qayyum M, Ashiq S, Khokhar R, et al. A comprehensive review on gout: the epidemiological trends, pathophysiology, clinical presentation, diagnosis and treatment. JPMA J Pak Med Assoc. 2021;71(4):1234\u20138.","journal-title":"JPMA J Pak Med Assoc"},{"issue":"8","key":"2461_CR2","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1016\/S2665-9913(24)00117-6","volume":"6","author":"GBD 2021 Gout Collaborators","year":"2024","unstructured":"GBD 2021 Gout Collaborators. Global, regional, and National burden of gout, 1990\u20132020, and projections to 2050: a systematic analysis of the global burden of disease study 2021. Lancet Rheumatol. 2024;6(8):e507\u201317.","journal-title":"Lancet Rheumatol"},{"issue":"9","key":"2461_CR3","first-page":"1068","volume":"62","author":"X Dong","year":"2023","unstructured":"Dong X, Xiaoxia ZH, Hejian Z, He L, Yan ZH. Guidelines for diagnosis and treatment of gout. Chin J Intern Med. 2023;62(9):1068\u201376.","journal-title":"Chin J Intern Med"},{"issue":"3","key":"2461_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/annrheumdis-2017-212063","volume":"77","author":"V Sigurdardottir","year":"2018","unstructured":"Sigurdardottir V, Drivelegka P, Sv\u00e4rd A, Jacobsson LTH, Dehlin M. Work disability in gout: a population-based case-control study. Ann Rheum Dis. 2018;77(3):399\u2013404.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2461_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3899\/jrheum.071229","volume":"36","author":"MA Becker","year":"2009","unstructured":"Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, et al. Quality of life and disability in patients with treatment-failure gout. J Rheumatol. 2009;36(5):1041\u20138.","journal-title":"J Rheumatol"},{"key":"2461_CR6","doi-asserted-by":"crossref","unstructured":"Xie S, Wu J, Xie F. Population Norms for SF-6Dv2 and EQ-5D-5L in China. Appl Health Econ Health Policy. 2022 July 1;20(4):573\u201385.","DOI":"10.1007\/s40258-022-00715-2"},{"key":"2461_CR7","doi-asserted-by":"crossref","unstructured":"Karimi M, Brazier J, Health. Health-related quality of life, and quality of life: What is the difference? PharmacoEconomics. 2016 July;34(7):645\u20139.","DOI":"10.1007\/s40273-016-0389-9"},{"key":"2461_CR8","doi-asserted-by":"publisher","first-page":"5471575","DOI":"10.1155\/2022\/5471575","volume":"2022","author":"P Paulsamy","year":"2022","unstructured":"Paulsamy P, Venkatesan K, Alshahrani S, Ahmad F, El-Sherbiny M, Manoharan V, et al. Alternate warm and cold therapy (AWCT) on Uricemia, Sleep, Pain, functional Ability, and quality of life (USPFQoL) in patients with gout: A path forward. J Healthc Eng. 2022;2022:5471575.","journal-title":"J Healthc Eng"},{"issue":"1","key":"2461_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13075-019-1918-7","volume":"21","author":"C Proudman","year":"2019","unstructured":"Proudman C, Lester SE, Gonzalez-Chica DA, Gill TK, Dalbeth N, Hill CL. Gout, flares, and allopurinol use: a population-based study. Arthritis Res Ther. 2019;21(1):132.","journal-title":"Arthritis Res Ther"},{"key":"2461_CR10","unstructured":"Schumacher HR, Taylor W, Joseph-Ridge N, Perez-Ruiz F, Chen LX, Schlesinger N et al. Outcome evaluations in gout. J Rheumatol."},{"issue":"11","key":"2461_CR11","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/rheumatology\/ket265","volume":"52","author":"P Chandratre","year":"2013","unstructured":"Chandratre P, Roddy E, Clarson L, Richardson J, Hider SL, Mallen CD. Health-related quality of life in gout: a systematic review. Rheumatol Oxf Engl. 2013;52(11):2031\u201340.","journal-title":"Rheumatol Oxf Engl"},{"issue":"7","key":"2461_CR12","first-page":"446","volume":"22","author":"G Qihong","year":"2018","unstructured":"Qihong G, Qianhua L, Baolin ZH, Tongguang Y, Yuanyi L, Benliu L, et al. The reliability and validity of short form-36 questionnaire in patients with gout. Chin J Rheumatol. 2018;22(7):446\u201351.","journal-title":"Chin J Rheumatol"},{"issue":"10","key":"2461_CR13","first-page":"1472","volume":"19","author":"L Ying","year":"2019","unstructured":"Ying L, Ting L, Xiuxin M, Xinyu Y, Can W, Changgui L, et al. Reliability and validity of the Chinese version of gout impact scale. Chin Nurs Manage. 2019;19(10):1472\u20137.","journal-title":"Chin Nurs Manage"},{"key":"2461_CR14","doi-asserted-by":"crossref","unstructured":"Singh JA, Taylor WJ, Simon LS, Khanna PP, Stamp LK, McQueen FM, et al. Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol. 2011 July;38(7):1452\u20137.","DOI":"10.3899\/jrheum.110271"},{"issue":"9","key":"2461_CR15","first-page":"1255","volume":"19","author":"MM van Groen","year":"2010","unstructured":"van Groen MM, ten Klooster PM, Taal E, van de Laar MAFJ, Glas CAW. Application of the health assessment questionnaire disability index to various rheumatic diseases. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2010;19(9):1255\u201363.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"2461_CR16","doi-asserted-by":"publisher","first-page":"1516146","DOI":"10.3389\/fimmu.2025.1516146","volume":"16","author":"A Abdellatif","year":"2025","unstructured":"Abdellatif A, Zhao L, Obermeyer K, Vranic Z, Marder BA, Scandling JD. Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial. Front Immunol. 2025;16:1516146.","journal-title":"Front Immunol"},{"key":"2461_CR17","doi-asserted-by":"crossref","unstructured":"Strand V, Khanna D, Singh JA, Forsythe A, Edwards NL. Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials. J Rheumatol. 2012 July;39(7):1450\u20137.","DOI":"10.3899\/jrheum.111375"},{"key":"2461_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.thromres.2017.03.016","volume":"153","author":"H De la Corte-Rodriguez","year":"2017","unstructured":"De la Corte-Rodriguez H, Rodriguez-Merchan EC. The Health assessment questionnaire disability index (HAQ-DI) as a valid alternative for measuring the functional capacity of people with haemophilia. Thromb Res. 2017;153:51\u20136.","journal-title":"Thromb Res"},{"issue":"5","key":"2461_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/art.23575","volume":"59","author":"E \u00c1lvarez-Hern\u00e1ndez","year":"2008","unstructured":"\u00c1lvarez-Hern\u00e1ndez E, Pel\u00e1ez\u2010Ballestas I, V\u00e1zquez\u2010Mellado J, Ter\u00e1n\u2010Estrada L, Bernard\u2010Medina AG, Espinoza J, et al. Validation of the health assessment questionnaire disability index in patients with gout. Arthritis Care Res. 2008;59(5):665\u20139.","journal-title":"Arthritis Care Res"},{"key":"2461_CR20","doi-asserted-by":"crossref","unstructured":"Citera G, Arriola MS, Maldonado-Cocco JA, Rosemffet MG, S\u00e1nchez MM, Go\u00f1i MA, et al. Validation and crosscultural adaptation of an argentine Spanish version of the health assessment questionnaire disability index. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2004 June;10(3):110\u20135.","DOI":"10.1097\/01.rhu.0000128732.58292.cd"},{"issue":"10","key":"2461_CR21","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1111\/1756-185X.13670","volume":"22","author":"B Vaidya","year":"2019","unstructured":"Vaidya B, Joshi R, Lama LD, Nakarmi S. Translation, cross-cultural adaptation and validation of Nepali version of health assessment Questionnaire-Disability index in rheumatoid arthritis patients from Nepal. Int J Rheum Dis. 2019;22(10):1871\u20136.","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"2461_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/rheumatology\/keq387","volume":"50","author":"PM Ten Klooster","year":"2011","unstructured":"Ten Klooster PM, Oude Voshaar MAH, Taal E, van de Laar MAFJ. Comparison of measures of functional disability in patients with gout. Rheumatol Oxf Engl. 2011;50(4):709\u201313.","journal-title":"Rheumatol Oxf Engl"},{"key":"2461_CR23","unstructured":"Taylor WJ, Colvine K, Gregory K, Collis J, McQueen FM, Dalbeth N. The health assessment questionnaire disability index is a valid measure of physical function in gout."},{"issue":"12","key":"2461_CR24","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1111\/1756-185X.12831","volume":"20","author":"H Hu","year":"2017","unstructured":"Hu H, Luan L, Yang K, Li SC. Psychometric validation of Chinese health assessment questionnaire for use in rheumatoid arthritis patients in China. Int J Rheum Dis. 2017;20(12):1987\u201392.","journal-title":"Int J Rheum Dis"},{"key":"2461_CR25","doi-asserted-by":"crossref","unstructured":"Liu D, Zhang C, Wang C, Liu J, Li D, Li J et al. Cross-cultural adaptation and validation of the Chinese version of the health assessment questionnaire for the spondyloarthropathies (HAQ-S). Clin Rheumatol. 2017 Sept 1;36(9):2027\u201333.","DOI":"10.1007\/s10067-017-3759-6"},{"key":"2461_CR26","doi-asserted-by":"crossref","unstructured":"Taylor WJ, McPherson KM. Using Rasch analysis to compare the psychometric properties of the short form 36 physical function score and the health assessment questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis. Arthritis Rheum 2007 June 15;57(5):723\u20139.","DOI":"10.1002\/art.22770"},{"key":"2461_CR27","doi-asserted-by":"crossref","unstructured":"Bruce B, Fries JF. The Stanford health assessment questionnaire: dimensions and practical applications. Health Qual Life Outcomes. 2003 June;9:1:20.","DOI":"10.1186\/1477-7525-1-20"},{"key":"2461_CR28","unstructured":"EQ-5D. -5LUserguide-Chinese-23-07.pdf [Internet]. [cited 2025 Oct 21]. Available from: https:\/\/euroqol-domain.ams3.digitaloceanspaces.com\/wp-content\/uploads\/2025\/01\/08035109\/EQ-5D-5LUserguide-Chinese-23-07.pdf"},{"issue":"10","key":"2461_CR29","first-page":"1727","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"2461_CR30","doi-asserted-by":"crossref","unstructured":"Devlin N, Pickard S, Busschbach J. The Development of the EQ-5D-5L and its Value Sets. In: Devlin N, Roudijk B, Ludwig K, editors. Value Sets for EQ-5D-5L: a compendium, comparative review & user guide [Internet]. Cham (CH): Springer; 2022 [cited 2024 Dec 22]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK589306\/.","DOI":"10.1007\/978-3-030-89289-0_1"},{"issue":"4","key":"2461_CR31","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","volume":"20","author":"N Luo","year":"2017","unstructured":"Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2017;20(4):662\u20139.","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"5","key":"2461_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/14737167.2025.2482667","volume":"25","author":"Y Liu","year":"2025","unstructured":"National Bureau of Statistics. China Statistical Yearbook 2024. Beijing: China Statistics Press; 2024. https:\/\/www.stats.gov.cn\/sj\/ndsj\/2024\/indexch.htm. Accessed 01 Nov 2025.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2461_CR33","doi-asserted-by":"crossref","unstructured":"Song J, Jin C, Shan Z, Teng W, Li J. Prevalence and risk factors of hyperuricemia and gout: a cross-sectional survey from 31 provinces in Mainland China. J Transl Intern Med. 2022 June;10(2):134\u201345.","DOI":"10.2478\/jtim-2022-0031"},{"issue":"5","key":"2461_CR34","first-page":"1147","volume":"27","author":"Ca Prinsen","year":"2018","unstructured":"Prinsen Ca, Mokkink C, Bouter LB, Alonso LM, Patrick J, de Vet DL. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2018;27(5):1147\u201357.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"8","key":"2461_CR35","first-page":"2197","volume":"30","author":"JJ Gagnier","year":"2021","unstructured":"Gagnier JJ, Lai J, Mokkink LB, Terwee CB. COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2021;30(8):2197\u2013218.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"3 Suppl","key":"2461_CR36","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1097\/00005650-198903001-00015","volume":"27","author":"LE Kazis","year":"1989","unstructured":"Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care. 1989;27(3 Suppl):S178\u2013189.","journal-title":"Med Care"},{"issue":"1","key":"2461_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1207\/S15327752JPA8001_18","volume":"80","author":"DL Streiner","year":"2003","unstructured":"Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess. 2003;80(1):99\u2013103.","journal-title":"J Pers Assess"},{"key":"2461_CR38","doi-asserted-by":"crossref","unstructured":"J\u00f6reskog KG. Testing a simple structure hypothesis in factor analysis. Psychometrika. 1966 June;31(2):165\u201378.","DOI":"10.1007\/BF02289505"},{"key":"2461_CR39","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1017\/SJP.2020.56","volume":"23","author":"D Ond\u00e9","year":"2020","unstructured":"Ond\u00e9 D, Alvarado JM. Reconsidering the conditions for conducting confirmatory factor analysis. Span J Psychol. 2020;23:e55.","journal-title":"Span J Psychol"},{"issue":"1","key":"2461_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10705519909540118","volume":"6","author":"Ltze Hu","year":"1999","unstructured":"Hu Ltze, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model- Multidiscip J. 1999;6(1):1\u201355.","journal-title":"Struct Equ Model- Multidiscip J"},{"issue":"5","key":"2461_CR41","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/rheumatology\/keu386","volume":"54","author":"N Cuperus","year":"2015","unstructured":"Cuperus N, Mahler EAM, Vliet Vlieland TPM, Hoogeboom TJ, van den Ende CH. Measurement properties of the health assessment questionnaire disability index for generalized osteoarthritis. Rheumatol Oxf Engl. 2015;54(5):821\u20136.","journal-title":"Rheumatol Oxf Engl"},{"issue":"1","key":"2461_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12955-024-02313-3","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X, Hong T, Luo C, Xie S, Wu J. Evaluation of measurement properties of the impact of weight on quality of Life-Lite (IWQOL-Lite) instrument among Chinese overweight and obese populations. Health Qual Life Outcomes. 2024;22(1):96.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"2461_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10198-023-01566-x","volume":"25","author":"S Xie","year":"2024","unstructured":"Xie S, Wu J, Chen G. Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population. Eur J Health Econ. 2024;25(1):7\u201319.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"2461_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/03007995.2019.1662990","volume":"36","author":"CH Pao","year":"2020","unstructured":"Pao CH, Ko Y. An assessment of the psychometric properties of the Chinese version of the gout impact scale. Curr Med Res Opin. 2020;36(1):17\u201321.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"2461_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12955-022-02003-y","volume":"20","author":"S Xie","year":"2022","unstructured":"Xie S, Wang D, Wu J, Liu C, Jiang W. Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey. Health Qual Life Outcomes. 2022;20(1):96.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"2461_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semarthrit.2017.12.005","volume":"48","author":"P Chandratre","year":"2018","unstructured":"Chandratre P, Mallen C, Richardson J, Muller S, Hider S, Rome K, et al. Health-related quality of life in gout in primary care: baseline findings from a cohort study. Semin Arthritis Rheum. 2018;48(1):61\u20139.","journal-title":"Semin Arthritis Rheum"},{"key":"2461_CR47","doi-asserted-by":"crossref","unstructured":"Khanna PP, Nuki G, Bardin T, Tausche AK, Forsythe A, Goren A et al. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: results from a cross-sectional survey. Health Qual LIFE OUTCOMES 2012 Sept 22;10:117.","DOI":"10.1186\/1477-7525-10-117"},{"issue":"8","key":"2461_CR48","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/acr.20479","volume":"63","author":"MAM DeMarco","year":"2011","unstructured":"DeMarco MAM, Maynard JW, Huizinga MM, Baer AN, K\u00f6ttgen A, Gelber AC, et al. Obesity and younger age at gout onset in a community-based cohort. Arthritis Care Res. 2011;63(8):1108\u201314.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"2461_CR49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12955-019-1137-6","volume":"17","author":"Z Ye","year":"2019","unstructured":"Ye Z, Sun L, Wang Q. A head-to-head comparison of EQ-5D-5L and SF-6D in Chinese patients with low back pain. Health Qual Life Outcomes. 2019;17(1):57.","journal-title":"Health Qual Life Outcomes"},{"key":"2461_CR50","doi-asserted-by":"crossref","unstructured":"Cohen J. A power primer. Psychol Bull. 1992 July;112(1):155\u20139.","DOI":"10.1037\/0033-2909.112.1.155"},{"issue":"02","key":"2461_CR51","first-page":"193","volume":"61","author":"Z Yaowei","year":"2022","unstructured":"Yaowei Z, Shuyan L, Chutao CH, Tao W, Xuepei ZH, Jianzi L, et al. The characteristics and associated factors of functional limitation in patients with rheumatoid arthritis. Chin J Intern Med. 2022;61(02):193\u20139.","journal-title":"Chin J Intern Med"},{"issue":"1","key":"2461_CR52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/rheumatology\/kew356","volume":"56","author":"JA Singh","year":"2017","unstructured":"Singh JA, Bharat A, Khanna D, Aquino-Beaton C, Persselin JE, Duffy E, et al. Racial differences in health-related quality of life and functional ability in patients with gout. Rheumatol Oxf Engl. 2017;56(1):103\u201312.","journal-title":"Rheumatol Oxf Engl"},{"key":"2461_CR53","doi-asserted-by":"crossref","unstructured":"Khanna D, Ahmed M, Yontz D, Ginsburg SS, Park GS, Leonard A et al. The disutility of chronic gout. Qual Life Res Int J Qual Life Asp Treat Care Rehabil 2008 June;17(5):815\u201322.","DOI":"10.1007\/s11136-008-9355-0"},{"issue":"1","key":"2461_CR54","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12887-020-02413-1","volume":"20","author":"D Malaeb","year":"2020","unstructured":"Malaeb D, Awad E, Haddad C, Salameh P, Sacre H, Akel M, et al. Bullying victimization among Lebanese adolescents: the role of child abuse, internet addiction, social phobia and depression and validation of the Illinois bully scale. BMC Pediatr. 2020;20(1):520.","journal-title":"BMC Pediatr"},{"key":"2461_CR55","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.2147\/PPA.S323393","volume":"15","author":"HF Chen","year":"2021","unstructured":"Chen HF, Lei N, Xu YM, Luo L, Zhang XL, Lao BN, et al. Is E-Version transition of the medication adherence scale feasible for CKD management? A pilot study. Patient Prefer Adherence. 2021;15:1785\u201393.","journal-title":"Patient Prefer Adherence"},{"issue":"5","key":"2461_CR56","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.sapharm.2020.07.027","volume":"17","author":"JB Schreiber","year":"2021","unstructured":"Schreiber JB. Issues and recommendations for exploratory factor analysis and principal component analysis. Res Soc Adm Pharm RSAP. 2021;17(5):1004\u201311.","journal-title":"Res Soc Adm Pharm RSAP"},{"issue":"3","key":"2461_CR57","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00467-019-04357-w","volume":"35","author":"J Lu","year":"2020","unstructured":"Lu J, Sun W, Cui L, Li X, He Y, Liu Z, et al. A cross-sectional study on uric acid levels among Chinese adolescents. Pediatr Nephrol Berl Ger. 2020;35(3):441\u20136.","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"11","key":"2461_CR58","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1177\/0300060518800114","volume":"46","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Wang D, Feng Y, Zhang W, Zeng X. Juvenile-onset gout and adipsic diabetes insipidus: A case report and literature review. J Int Med Res. 2018;46(11):4829\u201336.","journal-title":"J Int Med Res"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-025-02461-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-025-02461-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-025-02461-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:03:17Z","timestamp":1767794597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12955-025-02461-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2461"],"URL":"https:\/\/doi.org\/10.1186\/s12955-025-02461-0","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of this study was approved by the Academic Ethics Committee at Tianjin University (TJUE-2024-187) and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study. Participants were informed about their freedom of refusal. Anonymity and confidentiality were maintained throughout the research process.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent for publication was obtained from all individual participants. Participants were informed about their freedom of refusal for data publication. Anonymity and confidentiality were maintained in this publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}